Trial Profile
A retrospective study for the diagnosis of asymptomatic progressive multifocal leukoencephalopathy (PML) associated with natalizumab.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Jul 2016
Price :
$35
*
At a glance
- Drugs Natalizumab (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- 25 Jul 2016 New trial record.